Results 251 to 260 of about 85,902 (266)

Non-conventional Inhibitory CD4+Foxp3−PD-1hi T Cells as a Biomarker of Immune Checkpoint Blockade Activity

Cancer Cell, 2018
Roberta Zappasodi, Sadna Budhu, Matthew D Hellmann   +2 more
exaly  

EGFR mutation subtypes and response to immune checkpoint blockade treatment in non-small-cell lung cancer

Annals of Oncology, 2019
H A Yu, Jungmin Choi, H Rizvi
exaly  

Immune checkpoint blockade in desmoplastic melanoma

Nature Cancer
George Mo, Tara C. Mitchell
openaire   +2 more sources

Immune checkpoint blockade therapy for cancer: An overview of FDA-approved immune checkpoint inhibitors

International Immunopharmacology, 2018
KRISTIAN M Hargadon
exaly  

Immune-Related Adverse Events Associated with Immune Checkpoint Blockade

New England Journal of Medicine, 2018
Michael A Postow, Robert Sidlow, Matthew D Hellmann   +2 more
exaly  

mRNA Vaccine with Antigen-Specific Checkpoint Blockade Induces an Enhanced Immune Response against Established Melanoma

Molecular Therapy, 2018
Yuhua Wang, Zhenghong Xu, Lei Miao
exaly  

AMPK and immune checkpoint blockade

AMPK is a key sensor of energy stress, acting as a master regulator of cell metabolism. This protein is a heterotrimeric serine-threonine kinase which controls the inhibition of anabolic pathways and activation of catabolic pathways to maintain celular energy levels.
Valentines-Casas, Gerard, Universitat Autònoma de Barcelona. Facultat de Biociències   +1 more
openaire   +1 more source

Immune checkpoint blockade for unresectable or metastatic uveal melanoma: A systematic review

Cancer Treatment Reviews, 2017
Markus V Heppt, Theresa Steeb, Justin Gabriel Schlager   +2 more
exaly  

Immune Checkpoint Blockade

2019
openaire   +1 more source

Distinct Cellular Mechanisms Underlie Anti-CTLA-4 and Anti-PD-1 Checkpoint Blockade

Cell, 2017
Spencer C Wei, Alexandria P Cogdill, Yang Zhao   +2 more
exaly